Proteome-wide Mendelian randomization and therapeutic targets for bladder cancer
This study provides insights into the causal relationships of plasma proteins with BCa, identifying PSCA, LY6D, and SLURP1 as potential therapeutic targets, with implications for future BCa treatment strategies.
Authors
- Mingzhuang Zhang
- Menghua Wu (ORCID: https://orcid.org/0000-0003-0459-3723)
- Xiao‐Dong Hu (ORCID: https://orcid.org/0000-0001-8211-5677)
- Haixia Fan (ORCID: https://orcid.org/0009-0007-6404-2997)
Institutions
- Shanxi Medical University (CN)
- Capital Medical University (CN)
- Second People 's Hospital of Jinzhong (CN)
- First Hospital of Shanxi Medical University (CN)
- Beijing Hospital of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- BMC Urology
- Published
- 2024-12-21
- DOI
- https://doi.org/10.1186/s12894-024-01677-4
- Citations
- 1
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.57
Funders
- Shanxi Medical University